glp-1 and alcohol consumption Ozempic Other Drugs for Alcoholism: Do They Work? Frontiers | The therapeutic potential

For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate

S.LuoY.YuanK.HuangZ

Alongside this, he recommends identifying and addressing unhealthy eating habits contributing to weight gain

They need a simple way to see whether low-hunger days, water intake, protein, constipation, fatigue, cycle notes, and the scale are moving together or pulling in different directions

This information should be interpreted with a qualified healthcare provider to inform broader treatment decisions, especially when Medicaid coverage is limited or delayed